NIBRT’s unique bioprocessing training facility allows students the opportunity to learn and practice complex technical bioprocessing procedures.
NIBRT Coronavirus Update
In line with Government guidance, the NIBRT facility will re-open from June 8th 2020.
In advance of visiting NIBRT, all visitors must complete the attached questionnaire and return it to their NIBRT contact.
To ensure the health and safety of all at the facility, NIBRT has put in place comprehensive policies and procedures which are summarised here.
Our World Class Facility
The NIBRT facility is a purpose-built, multi-functional building which replicates the most modern industrial bioprocessing facility. The total building area is approximately 6,500 m² over two floors.
At the heart of the NIBRT building is the bioprocessing pilot plant, consisting of extensive upstream, downstream, fill-finish and the associated analytical facilities. These facilities are all operated in a realistic GMP simulated, operational manufacturing environment.
NIBRT Online Academy (NOA)
Developed by the award-winning NIBRT, the NIBRT Online Academy (NOA) is an online learning platform.
This new online training academy will allow trainees who may not be able to attend NIBRT to experience NIBRT training, online
A global centre of excellence for Training & Research
NIBRT is based on an innovative collaboration between University College Dublin, Trinity College Dublin, Dublin City University and the Institute of Technology, Sligo.
NIBRT was primarily funded by the Government of Ireland through Ireland’s inward investment promotion agency, IDA Ireland (Industrial Development Agency), which is responsible for the attraction and development of foreign investment in Ireland.
NIBRT offers a quality training and research experience not previously possible anywhere in the world.
Annual Biopharma Trends Survey
NIBRT and The Medicine Maker have announced the results of the third annual biopharma trends survey.
This annual survey explores the current manufacturing practices and trends in the biopharmaceutical industry.
Over 151 industry professionals participated in this survey.